2 completed, 1 recruiting, 1 unknown. 2 Phase 4, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Celiprolol: new trials by email Literature Review of Celiprolol trials Research Report on Celiprolol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome ACER-002 (celiprolol) 200 mg BID, Placebo BID - Vascular Ehlers-Danlos Syndrome | Phase 3 | Recruiting | Acer Therapeutics Inc. | 150 | 2022-11-07 | 2025-08-24 |
| Celiprolol Versus Ditiazem for the Prevention of Postoperative Cardiac Arrythmias in Thoracic Surgery Celiprolol, Diltiazem - Postoperative Cardiac Complication | Phase 2 | Unknown | Abderrahmane Mami Hospital | 30 | 2018-12-01 | 2018-11-26 |
| Chronic Beta-blockade and Cardiopulmonary Exercise in COPD Bisoprolol, Celiprolol - Chronic Obstructive Pulmonary Disease | Phase 4 | Completed | University of Dundee | 10 | 2016-06-07 | 2019-06-24 |
| Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type celiprolol, Control - EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT, CHROMOSOME 2q31.2 DELETION SYNDROME | Phase 4 | Completed | Assistance Publique - Hôpitaux de Paris | 54 | 2003-10-01 | 2013-01-16 |
Ehlers-Danlos Syndrome, Type IV (2) · Cardiovascular Diseases (1) · Chromosome 2q31.2 Deletion Syndrome (1) · Ehlers-Danlos Syndrome (1) · Pulmonary Disease, Chronic Obstructive (1)
Abderrahmane Mami Hospital (1) · Acer Therapeutics Inc. (1) · Assistance Publique - Hôpitaux de Paris (1) · University of Dundee (1)
Tunisia (1) · United Kingdom (1) · United States (1)
Marzouk Mahmoud, MD (1) · William J Anderson, MBCHB (1)
2015 (1)